marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Leap Therapeutics Financial Ratios 2011-2024 | LPTX
Annual Financial Ratios Leap Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -0.1 | -6.9 | -6.5 | -1.3 | -1.3 | -2.2 | -2.7 | - | - | - | - | - |
P/S |
- | - | 185.4 | 118.6 | - | - | - | - | - | - | - | - | - |
EPS |
-4.0 | -4.8 | -0.5 | -0.6 | -1.5 | -1.6 | -3.3 | - | - | - | - | - | - |
EV (Enterprise Value) |
-14.2 M | -50.5 M | 173 M | 133 M | 47.5 M | 24.4 M | 56.6 M | 75 M | 1.28 M | 2.49 M | 1.97 M | 4.61 M | - |
EBITDA per Share |
-4.26 | -5.01 | -0.48 | -0.37 | -1.47 | -2.12 | -3.53 | -2.6 | - | - | - | - | - |
EV/EBITDA |
-3.7 | -4.5 | -1.2 | -0.5 | -1.2 | -2.8 | - | - | - | - | - | ||
PEG |
-0.0 | -0.0 | 0.43 | -0.38 | -0.12 | -0.03 | 0.02 | 0.09 | - | - | - | - | - |
P/B |
0.7 | 0.1 | 2.6 | 3.8 | -24.1 | 3.4 | 5.8 | -0.7 | - | - | - | - | - |
P/CF |
-1.0 | -0.1 | -7.9 | -6.9 | -1.6 | -1.2 | -2.9 | -2.7 | - | - | - | - | - |
ROE % |
-135.37 | -92.75 | -37.62 | -58.98 | 1881.07 | -252.19 | -267.40 | 25.57 | - | - | - | - | - |
ROA % |
-111.79 | -77.60 | -34.42 | -50.60 | -441.73 | -121.31 | -102.29 | -396.96 | - | - | - | - | - |
ROCE % |
-144.73 | -96.43 | -38.40 | -60.23 | 3209.92 | -237.62 | -140.79 | 92.66 | - | - | - | - | - |
Current Ratio |
5.7 | 6.1 | 11.8 | 7.1 | 0.5 | 2.7 | 4.5 | 0.1 | - | - | - | - | - |
DSO |
- | - | - | 17.8 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Leap Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.44 | -0.52 | -0.51 | - | -0.51 | -0.91 | -3.24 | - | -1.33 | -1.5 | -0.09 | - | -0.14 | -0.12 | -0.12 | - | -0.09 | -0.12 | -0.55 | - | -0.33 | -0.37 | -0.47 | - | -0.45 | -0.5 | -0.85 | - | -0.73 | -0.74 | -1.39 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.55 | - | - | - | -3.3 | - | -1.35 | -1.49 | -0.09 | - | -0.15 | -0.13 | -0.12 | - | -0.1 | -0.14 | -0.2 | - | -0.33 | -0.37 | -0.46 | - | -0.58 | -0.46 | -0.51 | - | -0.91 | -0.74 | -1.47 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-115.92 | -97.81 | -83.14 | -182.72 | -204.26 | -206.78 | -211.29 | -52.50 | -62.04 | -50.03 | -61.48 | -65.21 | -80.34 | -85.93 | -68.02 | -44.59 | 409.09 | 877.91 | 1370.21 | 1423.90 | 1351.62 | 825.64 | 267.05 | -268.32 | -329.62 | -318.64 | -300.49 | -208.10 | -200.84 | -132.27 | -62.70 | 19.86 | 19.86 | 12.59 | 5.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-93.00 | -81.55 | -70.80 | -69.75 | -88.12 | -90.00 | -94.10 | -46.24 | -54.94 | -45.26 | -52.30 | -53.75 | -66.72 | -71.01 | -57.88 | -38.26 | -144.80 | -238.36 | -338.70 | -334.37 | -369.14 | -297.37 | -223.65 | -129.07 | -152.52 | -141.20 | -126.35 | -79.60 | -192.30 | -281.55 | -373.59 | -308.21 | -308.21 | -195.51 | -79.71 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-120.67 | -104.80 | -89.94 | -188.86 | -210.68 | -211.90 | -214.74 | -52.89 | -63.28 | -51.86 | -63.78 | -66.50 | -82.60 | -88.30 | -72.15 | -45.84 | 407.16 | 876.26 | 1376.09 | 1439.62 | 1345.90 | 799.18 | 240.90 | -237.38 | -314.58 | -298.06 | -286.65 | -232.13 | -225.12 | -140.91 | -70.62 | 19.32 | 19.32 | 12.31 | 5.13 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.0 | 5.2 | 5.5 | 5.7 | 7.5 | 8.1 | 10.1 | 6.1 | 6.8 | 8.7 | 14.4 | 11.8 | 11.4 | 4.7 | 6.2 | 7.0 | 7.0 | 7.0 | 7.0 | 0.8 | 0.8 | 0.8 | 0.8 | 1.9 | 1.9 | 1.9 | 1.9 | 1.6 | 1.6 | 1.6 | 1.6 | 0.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency